All In MedTech

FDA Clearance Tracker · P990004-S007

SURGIFOAM ABSORBABLE GELATIN SPONGE, U.S.P

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 7, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 7, 2005

Approved

Time to decision

52 days

Received Nov 16, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P990004-S007
Device name
SURGIFOAM ABSORBABLE GELATIN SPONGE, U.S.P
Applicant location
Soeborg
Received
Nov 16, 2004
Decided
Jan 7, 2005
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Express GMP Supplement
Original approval
P990004

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A NEW STERILIZATION SITE LOCATED AT ISOTRON PLC, SWINDON, UNITED KINGDOM.

Source documents

Other decisions for Ferrosan Meidcal Devices A/S

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.